FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048584758> ?p ?o ?g. }

• W3048584758 endingPage "190" @default.
• W3048584758 startingPage "183" @default.
• W3048584758 abstract "Background Dapagliflozin is an antidiabetic medication that has been shown to reduce the risk of heart failure hospitalization and cardiovascular death in patients with heart failure with reduced ejection fraction (HFrEF). This study aimed to determine the cost-utility of add-on dapagliflozin treatment for HFrEF. Methods An analytical decision model was constructed to assess lifetime costs and outcomes from a healthcare system perspective. The cohort comprised HFrEF patients with left ventricular ejection fraction (LVEF) ≤40%, and New York Heart Association (NYHA) class II–IV with an average age of 65 years. Clinical inputs were derived from the results of the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure (DAPA-HF) trial. Risk of non-cardiovascular death data, readmission rate data, and treatment-related cost data were based on Thai population. The outcomes and costs were discounted at 3% annually. A series of sensitivity analyses were also conducted. Results The increased cost of dapagliflozin add-on treatment from 17,442 THB (559 USD) to 54,405 THB (1745 USD) was associated with a QALY gain from 6.33 to 6.92 compared to standard therapy, yielding an ICER of 62,090 THB/QALY (1991 USD/QALY). Sensitivity analyses revealed that the addition of dapagliflozin to the standard treatment demonstrated an 87% cost-effectiveness strategy at a level of willingness to pay (WTP) of 160,000 THB/QALY (5131 USD/QALY). ICER was higher in non-diabetes compared to diabetes (68,304 vs 47,613 THB/QALY or 2191 vs 1527 USD/QALY). Conclusions Dapagliflozin is a cost-effective add-on therapy for patients with HFrEF at a WTP of 160,000 THB/QALY (5131 USD/QALY)." @default.
• W3048584758 created "2020-08-18" @default.
• W3048584758 creator A5012746805 @default.
• W3048584758 creator A5069679265 @default.
• W3048584758 date "2021-01-01" @default.
• W3048584758 modified "2023-10-16" @default.
• W3048584758 title "Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction" @default.
• W3048584758 cites W1527372360 @default.
• W3048584758 cites W1977483151 @default.
• W3048584758 cites W1985508196 @default.
• W3048584758 cites W2061382057 @default.
• W3048584758 cites W2064130493 @default.
• W3048584758 cites W2113698123 @default.
• W3048584758 cites W2126617656 @default.
• W3048584758 cites W2143239235 @default.
• W3048584758 cites W2146264128 @default.
• W3048584758 cites W2150561315 @default.
• W3048584758 cites W2315712189 @default.
• W3048584758 cites W2398251311 @default.
• W3048584758 cites W2401773418 @default.
• W3048584758 cites W2418302338 @default.
• W3048584758 cites W2427094903 @default.
• W3048584758 cites W2562509504 @default.
• W3048584758 cites W2606994751 @default.
• W3048584758 cites W2609605008 @default.
• W3048584758 cites W2610602137 @default.
• W3048584758 cites W2626446274 @default.
• W3048584758 cites W2742824716 @default.
• W3048584758 cites W2787404436 @default.
• W3048584758 cites W2791928563 @default.
• W3048584758 cites W2809099805 @default.
• W3048584758 cites W2884466498 @default.
• W3048584758 cites W2900413769 @default.
• W3048584758 cites W2945994263 @default.
• W3048584758 cites W2972361782 @default.
• W3048584758 cites W2974260792 @default.
• W3048584758 cites W2980072629 @default.
• W3048584758 cites W2999323696 @default.
• W3048584758 cites W3008473973 @default.
• W3048584758 doi "https://doi.org/10.1016/j.ijcard.2020.08.017" @default.
• W3048584758 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32800910" @default.
• W3048584758 hasPublicationYear "2021" @default.
• W3048584758 type Work @default.
• W3048584758 sameAs 3048584758 @default.
• W3048584758 citedByCount "27" @default.
• W3048584758 countsByYear W30485847582021 @default.
• W3048584758 countsByYear W30485847582022 @default.
• W3048584758 countsByYear W30485847582023 @default.
• W3048584758 crossrefType "journal-article" @default.
• W3048584758 hasAuthorship W3048584758A5012746805 @default.
• W3048584758 hasAuthorship W3048584758A5069679265 @default.
• W3048584758 hasConcept C112930515 @default.
• W3048584758 hasConcept C126322002 @default.
• W3048584758 hasConcept C134018914 @default.
• W3048584758 hasConcept C164705383 @default.
• W3048584758 hasConcept C184834754 @default.
• W3048584758 hasConcept C2777180221 @default.
• W3048584758 hasConcept C2777422806 @default.
• W3048584758 hasConcept C2778198053 @default.
• W3048584758 hasConcept C2908647359 @default.
• W3048584758 hasConcept C3019080777 @default.
• W3048584758 hasConcept C555293320 @default.
• W3048584758 hasConcept C71924100 @default.
• W3048584758 hasConcept C72563966 @default.
• W3048584758 hasConcept C78085059 @default.
• W3048584758 hasConcept C99454951 @default.
• W3048584758 hasConceptScore W3048584758C112930515 @default.
• W3048584758 hasConceptScore W3048584758C126322002 @default.
• W3048584758 hasConceptScore W3048584758C134018914 @default.
• W3048584758 hasConceptScore W3048584758C164705383 @default.
• W3048584758 hasConceptScore W3048584758C184834754 @default.
• W3048584758 hasConceptScore W3048584758C2777180221 @default.
• W3048584758 hasConceptScore W3048584758C2777422806 @default.
• W3048584758 hasConceptScore W3048584758C2778198053 @default.
• W3048584758 hasConceptScore W3048584758C2908647359 @default.
• W3048584758 hasConceptScore W3048584758C3019080777 @default.
• W3048584758 hasConceptScore W3048584758C555293320 @default.
• W3048584758 hasConceptScore W3048584758C71924100 @default.
• W3048584758 hasConceptScore W3048584758C72563966 @default.
• W3048584758 hasConceptScore W3048584758C78085059 @default.
• W3048584758 hasConceptScore W3048584758C99454951 @default.
• W3048584758 hasLocation W30485847581 @default.
• W3048584758 hasOpenAccess W3048584758 @default.
• W3048584758 hasPrimaryLocation W30485847581 @default.
• W3048584758 hasRelatedWork W2051712573 @default.
• W3048584758 hasRelatedWork W2077083067 @default.
• W3048584758 hasRelatedWork W2091139515 @default.
• W3048584758 hasRelatedWork W2355594703 @default.
• W3048584758 hasRelatedWork W3033076790 @default.
• W3048584758 hasRelatedWork W3033514737 @default.
• W3048584758 hasRelatedWork W3085461774 @default.
• W3048584758 hasRelatedWork W3164477560 @default.
• W3048584758 hasRelatedWork W4293354639 @default.
• W3048584758 hasRelatedWork W4382048704 @default.
• W3048584758 hasVolume "322" @default.
• W3048584758 isParatext "false" @default.
• W3048584758 isRetracted "false" @default.
• W3048584758 magId "3048584758" @default.

• next